Sol Efroni

4.2k total citations · 1 hit paper
76 papers, 2.8k citations indexed

About

Sol Efroni is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Sol Efroni has authored 76 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 19 papers in Immunology and 16 papers in Oncology. Recurrent topics in Sol Efroni's work include T-cell and B-cell Immunology (17 papers), Gene Regulatory Network Analysis (11 papers) and Immune Cell Function and Interaction (11 papers). Sol Efroni is often cited by papers focused on T-cell and B-cell Immunology (17 papers), Gene Regulatory Network Analysis (11 papers) and Immune Cell Function and Interaction (11 papers). Sol Efroni collaborates with scholars based in Israel, United States and France. Sol Efroni's co-authors include Rotem Ben‐Hamo, Irun R. Cohen, Kenneth H. Buetow, David Harel, Eran Meshorer, Yoram Louzoun, Tom Misteli, Jennifer I. C. Benichou, Carl F. Schaefer and Hesam Dehghani and has published in prestigious journals such as Science, Nature Communications and Nano Letters.

In The Last Decade

Sol Efroni

72 papers receiving 2.7k citations

Hit Papers

Global Transcription in Pluripotent Embryonic Stem Cells 2008 2026 2014 2020 2008 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sol Efroni Israel 27 1.7k 628 419 371 208 76 2.8k
Maayan Baron United States 17 1.7k 1.0× 425 0.7× 586 1.4× 439 1.2× 520 2.5× 40 2.8k
Nathalie Pochet United States 23 1.6k 0.9× 460 0.7× 417 1.0× 188 0.5× 353 1.7× 52 2.9k
Rong Rong China 32 2.1k 1.2× 398 0.6× 819 2.0× 375 1.0× 201 1.0× 130 3.6k
Stephanie C. Hicks United States 31 2.4k 1.4× 359 0.6× 491 1.2× 281 0.8× 273 1.3× 87 4.2k
Saurabh Saha United States 22 2.0k 1.1× 517 0.8× 572 1.4× 833 2.2× 231 1.1× 46 3.3k
Julio Vera Germany 31 2.2k 1.3× 368 0.6× 954 2.3× 399 1.1× 163 0.8× 138 3.2k
André F. Rendeiro Austria 20 2.3k 1.3× 696 1.1× 330 0.8× 295 0.8× 264 1.3× 32 3.3k
Robert V. Bruggner United States 11 2.4k 1.4× 1.1k 1.8× 244 0.6× 412 1.1× 88 0.4× 15 3.5k
Junfei Zhao United States 25 1.6k 1.0× 284 0.5× 587 1.4× 398 1.1× 224 1.1× 81 2.4k

Countries citing papers authored by Sol Efroni

Since Specialization
Citations

This map shows the geographic impact of Sol Efroni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sol Efroni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sol Efroni more than expected).

Fields of papers citing papers by Sol Efroni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sol Efroni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sol Efroni. The network helps show where Sol Efroni may publish in the future.

Co-authorship network of co-authors of Sol Efroni

This figure shows the co-authorship network connecting the top 25 collaborators of Sol Efroni. A scholar is included among the top collaborators of Sol Efroni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sol Efroni. Sol Efroni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zilberberg, Alona, et al.. (2025). RNA-seq based T cell repertoire extraction compared with TCR-seq. PubMed. 6(1). iqaf001–iqaf001.
2.
Aviel‐Ronen, Sarit, et al.. (2024). Ovarian cancer is detectable from peripheral blood using machine learning over T-cell receptor repertoires. Briefings in Bioinformatics. 25(2). 7 indexed citations
3.
Zilberberg, Alona, Moriah Gidoni, Raanan Margalit, et al.. (2021). Breast cancer is marked by specific, Public T-cell receptor CDR3 regions shared by mice and humans. PLoS Computational Biology. 17(1). e1008486–e1008486. 12 indexed citations
4.
Ben‐Hamo, Rotem, A. Berger, Nancy Gavert, et al.. (2020). Predicting and affecting response to cancer therapy based on pathway-level biomarkers. Nature Communications. 11(1). 3296–3296. 52 indexed citations
5.
Anderson, David E., Alona Zilberberg, Max J. Gordon, et al.. (2020). 1061P TCR and HLA analysis of patients in a phase I/IIa trial of a therapeutic CMV vaccine against recurrent glioblastoma (GBM). Annals of Oncology. 31. S724–S724. 1 indexed citations
6.
Levy, Orr, Guy Amit, Sol Efroni, et al.. (2020). Age-related loss of gene-to-gene transcriptional coordination among single cells. Nature Metabolism. 2(11). 1305–1315. 32 indexed citations
7.
Ben‐Hamo, Rotem, Alona Zilberberg, Helit Cohen, et al.. (2019). Resistance to paclitaxel is associated with a variant of the gene BCL2 in multiple tumor types. npj Precision Oncology. 3(1). 12–12. 27 indexed citations
8.
Osovski, Shmuel, et al.. (2019). Design principles of biologically fabricated avian nests. Scientific Reports. 9(1). 4792–4792. 12 indexed citations
9.
Cohen, Reuven, et al.. (2019). Digitizable therapeutics for decentralized mitigation of global pandemics. Scientific Reports. 9(1). 14345–14345. 4 indexed citations
10.
Zhu, Yinghua, Yujie Liu, Chao Zhang, et al.. (2018). Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1. Nature Communications. 9(1). 1595–1595. 110 indexed citations
11.
Morales, Cristina, Alva Biran, Harshil Patel, et al.. (2016). The linker histone H1.0 generates epigenetic and functional intratumor heterogeneity. Science. 353(6307). 132 indexed citations
12.
Porath, Hagit T., Michal Barák, Yishay Pinto, et al.. (2015). Fmrp Interacts with Adar and Regulates RNA Editing, Synaptic Density and Locomotor Activity in Zebrafish. PLoS Genetics. 11(12). e1005702–e1005702. 67 indexed citations
13.
Ben‐Hamo, Rotem, et al.. (2012). RBM38 Is a Direct Transcriptional Target of E2F1 that Limits E2F1-Induced Proliferation. Molecular Cancer Research. 10(9). 1169–1177. 30 indexed citations
15.
Efroni, Sol, Rotem Ben‐Hamo, Michael N. Edmonson, et al.. (2011). Detecting Cancer Gene Networks Characterized by Recurrent Genomic Alterations in a Population. PLoS ONE. 6(1). e14437–e14437. 22 indexed citations
16.
Harel, David, et al.. (2011). Reactive animation: From piecemeal experimentation to reactive biological systems. Autoimmunity. 44(4). 271–281. 5 indexed citations
17.
Efroni, Sol, Shai Melcer, Malka Nissim‐Rafinia, & Eran Meshorer. (2009). Stem cells do play with dice: A statistical physics view of transcription. Cell Cycle. 8(1). 43–48. 17 indexed citations
18.
Efroni, Sol, Jinming Cheng, Hesam Dehghani, et al.. (2008). Promiscuous global transcription in pluripotent embryonic stem cells. Cell stem cell. 12 indexed citations
19.
Efroni, Sol, David Harel, & Irun R. Cohen. (2007). Emergent Dynamics of Thymocyte Development and Lineage Determination. PLoS Computational Biology. 3(1). e13–e13. 55 indexed citations
20.
Efroni, Sol, David Harel, & Irun R. Cohen. (2003). Toward Rigorous Comprehension of Biological Complexity: Modeling, Execution, and Visualization of Thymic T-Cell Maturation. Genome Research. 13(11). 2485–2497. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026